ALNYLAM PHARMACEUTICALS, INC. 4 filing

Filed 2026-02-17 · Report date 2026-02-12 · 2026

View Original SEC Filing

Filing metadata

Accession number: 0001735276-26-000028
Form type: 4
CIK: 0001178670
Primary document: https://www.sec.gov/Archives/edgar/data/1178670/000173527626000028/xslF345X05/edgardoc.xml

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for ALNYLAM PHARMACEUTICALS, INC..

Reported financial metrics

Metric	Current	Prior	Change